1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. STK33

STK33 (丝氨酸/苏氨酸激酶 33)

Serine/threonine kinase 33

Serine/Threonine Kinase 33 (STK33) 在癌细胞增殖和转移中发挥关键作用,通过在蛋白质上磷酸化丝氨酸和苏氨酸残基,调节信号转导、DNA 复制、细胞分化、增殖、凋亡和肿瘤发展等重要的细胞过程。STK33 在胰腺癌、肺癌和肝癌中的表达显著高于相应的非癌组织。值得注意的是,STK33 在胃癌中激活 PI3K/Akt/mTOR 信号通路,促进癌细胞转移。此外,STK33/ERK2 信号通路通过磷酸化 ERK2,增强其活性,并促进结肠癌的肿瘤发生。STK33 在癌症发展中的参与凸显了其在肿瘤学研究中的重要性[1][2].。

Serine/Threonine Kinase 33 (STK33) plays a pivotal role in cancer cell proliferation and metastasis by phosphorylating serine and threonine residues on proteins, thereby regulating crucial cellular processes such as signal transduction, DNA replication, cell differentiation, proliferation, apoptosis, and tumor development. STK33 is overexpressed in various cancers, including pancreatic, lung, and liver cancers, compared to non-cancerous tissues. Notably, STK33 activates the PI3K/Akt/mTOR signaling pathway in gastric cancer, promoting metastasis. Additionally, the STK33/ERK2 signaling pathway contributes to the tumorigenesis of colorectal cancer by phosphorylating ERK2, enhancing its activity and promoting cancer progression. STK33's involvement in cancer development underscores its importance in oncology research.[1][2].

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-13495
    ML281 Inhibitor 99.91%
    ML281是一个强的,有选择性的STK33抑制剂,IC50值是14 nM。
    ML281
  • HY-162565
    CDD-2807 Inhibitor
    CDD-2807 是一种丝氨酸/苏氨酸激酶 33 (STK33) 抑制剂,IC50 为 9.2 nM。CDD-2807 小鼠无明显毒性,可穿过血睾屏障而不会在脑中蓄积。CDD-2807 可产生可逆的避孕效果,具有开发男性避孕药的潜力。
    CDD-2807
  • HY-13497
    STK33-IN-1 Inhibitor
    STK33-IN-1 (compound 1) 是STK33 的抑制剂,其 IC50 值为 7 nM。
    STK33-IN-1
  • HY-13498
    BRD-8899 Inhibitor
    BRD-8899是STK33 的抑制剂,其 IC50 值为 11 nM。
    BRD-8899
目录号 产品名 / 同用名 应用 反应物种